BioThrust

📍 Aachen, Germany🗓 Founded 2022👥 28 employees💰 Last funded Jan 2024
Biotechnology Research
LinkedIn
We are BioThrust, a biotech startup based in Germany that brings (sensitive) cell production to industrial scales. Our bionic bioreactor employs an artificial lung, providing stress-free cultivation conditions to achieve higher cell concentrations and quality. Through our patented membrane stirrer, we provide bubble-free gas exchange for any process. The formation of foam is completely avoided while gas transfer rates are 30x what conventional bioreactors offer. Our membranes allow you to increase your space-time yield by up to 250% without harming cells. By efficiently scaling the cell cultivation process, we help provide affordable stem cell therapies as well as driving progress in other sectors like cultured meat and synthetic biologics. We are a spin-off from the RWTH Aachen, on a mission to make stem cell therapy accessible for everyone.
3
Total investors
3
Early stage
0
Mid stage
0
Late stage
2022
Founded

Investors

3 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Germany
3
Frequently asked questions
Who invested in BioThrust?
BioThrust has 3 investors on record on gritt.io, including 3 early-stage backers.
When did BioThrust last raise funding?
The most recent investment in BioThrust recorded on gritt.io was in January 2024.
When was BioThrust founded?
BioThrust was founded in 2022.
What industry is BioThrust in?
BioThrust operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is BioThrust based?
BioThrust is headquartered in Aachen, Germany.